Concepedia

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

Mark Sulkowski, Stanislas Pol, Josep Mallolas, Hugo Fainboim, Curtis Cooper, Jihad Slim, Antonio Rivero, Carmen Mak, Seth Thompson, Anita YM Howe,

The Lancet Infectious Diseases · 2013 · 182 citations · 16 references

DOI

Concepts

References

16

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

, , +17

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Fred Poordad, Jonathan McCone, Bruce R. Bacon et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

, , +17

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text

, , +17

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

Gilbert Greub, B Ledergerber, Manuel Battegay et al. · The Lancet · 2000 · 903 citations

, , +16

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients

Montserrat Laguno, Javier Murillas, José Luís Blanco et al. · AIDS · 2004 · 388 citations

, , +17